NURS 6521N Week 9 Quiz / NURS6521 Week 9 Quiz (4 NEW Versions,140 Q/A):Walden University

NURS 6521N Week 9 Quiz / NURS6521 Week 9 Quiz (4 Latest Versions): Advanced Pharmacology: Walden University

Walden University NURS 6521N Week 9 Quiz / Walden University NURS6521 Week 9 Quiz (4 Latest Versions)

Question 1

A 45-year-old woman with acute leukemia is going to begin chemotherapy with vincristine. The nurse is aware that vincristine must always be administered

A.

at a rapid infusion rate.

B.

at a slow infusion rate.

C.

through a central line.

D.

through an IV line primed with vincristine.

1 points  

Question 2

A 62-year-old patient taking tamoxifen exhibits increased bone and tumor pain along with a local disease flare. The nurse interprets this as an indication of which of the following?

A.

A hypersensitivity reaction

B.

Cardiomyopathy

C.

Nephrotoxic effects of tamoxifen

D.

The tumor responding to treatment

1 points  

Question 3

A middle-aged patient has received a diagnosis of GI stromal tumor following an extensive diagnostic workup. Imatinib has been recommended as a component of the patient's drug regimen. What patient education should the nurse provide to this patient?

A.

“If you experience significant nausea after taking a dose, stop taking the drug and schedule an appointment at the clinic.”

B.

“Try to keep your PICC line dressing as dry as possible at all times.”

C.

“It's important that you let us know if you develop any significant swelling or puffiness.”

D.

“You'll likely experience a lot of dry mouth while you're taking this drug, so it's helpful to chew ice chips.”

1 points  

Question 4

A nurse has completed a medication reconciliation of a patient who has been admitted following a motor vehicle accident. Among the many drugs that the patient has received in the previous year is rituximab. The nurse would be justified in suspecting the patient may have received treatment for which of the following diseases?

A.

Malignant melanoma

B.

Non-Hodgkin's lymphoma

C.

Nonsmall cell lung cancer

D.

Renal cell carcinoma

1 points  

Question 5

A nurse has been assigned to a 55-year-old woman who has a malignant brain tumor. The patient is receiving her first dose of carmustine. It will be critical for the nurse to observe for which of the following?

A.

Inability to drink fluids for 6 hours

B.

Nausea and vomiting

C.

Reddish urine

D.

Respiratory difficulty

1 points  

Question 6

A nurse is caring for a 64-year-old female patient who is receiving IV heparin and reports bleeding from her gums. The nurse checks the patient's laboratory test results and finds that she has a very high aPTT. The nurse anticipates that which of the following drugs may be ordered?

A.

Alteplase

B.

Coumadin

C.

Ticlopidine

D.

Protamine sulfate

1 points  

Question 7

An older adult woman has been diagnosed with acute lymphoblastic leukemia (ALL) and her care team has identified potential benefits of imatinib. Which of the following characteristics of this patient's current health status may preclude the use of imatinib?

A.

The patient has type 2 diabetes mellitus that is controlled using diet and oral antihyperglycemics.

B.

The patient had a total knee arthroplasty several months earlier.

C.

The patient has chronic heart failure resulting in significant peripheral edema.

D.

The patient experienced a mild ischemic stroke several years ago and had transient ischemic attacks last year.

1 points  

Question 8

An oncology nurse is reviewing the pathophysiology of cancer and is discussing with a colleague the factors that contribute to the success or failure of a patient's chemotherapy. Which of the following cancerous cells is most susceptible to the effects of chemotherapeutic drugs?

A.

Cells that lack a blood supply

B.

Cells that lack contact inhibition

C.

Cells with a long generation time

D.

Cells that have a rapid mitotic rate

1 points  

Question 9

Mr. Lepp is a 63-year-old man who was diagnosed with colon cancer several weeks ago and who is scheduled to begin chemotherapy. He reports to the nurse that he read about the need for erythropoietin in an online forum for cancer patients and wants to explore the use of epoetin alfa with his oncologist. Which of the following facts should underlie the nurse's response to Mr. Lepp?

A.

Treatment with epoetin alfa will likely begin 4 to 6 days before Mr. Lepp's first round of chemotherapy and continue indefinitely.

B.

Mr. Lepp's oncologist should have begun treatment with epoetin alfa immediately after he was diagnosed.

C.

The potential benefits of epoetin alfa must be weighed carefully against the potential adverse effects in cancer patients.

D.

Epoetin alfa is normally contraindicated in patients who are receiving radiotherapy or chemotherapy.

1 points  

Question 10

A 28-year-old woman has completed rituximab therapy for an autoimmune disease. She tells the nurse that she and her husband would like to start a family. The nurse will advise her to

A.

pursue fertility testing.

B.

discontinue birth control, but avoid breast-feeding after the child is born.

C.

continue using birth control for at least 12 months.

D.

stop using birth control for the next several weeks.

1 points  

Question 11

Mr. Singh is a 66-year-old man who is receiving chemotherapy for the treatment of lung cancer that has metastasized to his liver. In an effort to prevent infection, Mr. Singh has been prescribed filgrastim (Neupogen). Which of the nurse's following assessment questions most directly addresses a common adverse effect of filgrastim?

A.

“Do you feel like you're having any pain in your bones?”

B.

“Have you had any shortness of breath lately?”

C.

“Are you experiencing any waves of cool, clammy skin?”

D.

“Have you noticed any bleeding in your gums or cheeks?”

1 points  

Question 12

A patient with chronic lymphocytic leukemia (CLL) will imminently begin a course of treatment with rituximab. In order to minimize the risk of adverse effects, what strategy for administration will be adopted?

A.

Administering the initial doses by slow infusion while observing for adverse reactions

B.

Admitting the patient to the intensive care unit in anticipation of the initial bolus of the drug

C.

Administering the drug by slow infusion to two peripheral IV sites simultaneously

D.

Administering diphenhydramine 30 minutes prior to the initial dose of rituximab

1 points  

Question 13

A patient will soon begin targeted therapy as a component of her treatment plan for chronic leukemia. The nurse is conducting health education about this new aspect of the patient's drug regimen and the patient has asked about the potential side effects of treatment. How should the nurse best respond?

A.

“The adverse effects to targeted therapies are most often a result of the patient's cancer, not the drugs themselves.”

B.

“Both classes of drugs have adverse effects, but targeted therapies tend to have less of an effect on healthy body cells.”

C.

“Chemotherapy causes a lot of unpleasant side effects, and the advantage of targeted therapies is that these are all avoided.”

D.

“Targeted therapies are often more effective than traditional chemotherapy, but the downside of this effectiveness is that adverse effects are more common and severe.”

1 points  

Question 14

A patient has been scheduled to begin treatment with rituximab for non-Hodgkin's lymphoma. The nurse who will administer this drug should understand that it targets

A.

the DNA of mature plasma cells.

B.

the molecular structure of the cells making up the semipermeable membrane of cancerous cells.

C.

the function of the complement system.

D.

specific antigens on the surface of malignant B cells.

1 points  

Question 15

A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome?

A.

Ensure that the patient maintains a normal breathing pattern.

B.

Protect the patient from exposure to infections.

C.

Ensure that the patient maintains a normal fluid and electrolyte balance.

D.

Monitor the patient for deterioration in renal function.

1 points  

Question 16

A patient receiving high-dose cisplatin therapy exhibits symptoms of hypomagnesemia. Which of the following should the nurse suggest to help offset the magnesium losses from the cisplatin therapy?

A.

Consuming chocolates

B.

Consuming dairy products

C.

Consuming potassium-rich foods

D.

Drinking 2 to 3 liters of fluid a day

1 points  

Question 17

During ongoing assessment of a patient receiving 5-FU therapy, the nurse finds the patient's platelet count to be 92,000 cells/mm3. The nurse should do which of the following?

A.

Continue the therapy as prescribed

B.

Consult the prescriber for discontinuation of the drug

C.

Consult the prescriber for a decrease in dosage

D.

Consult the prescriber for an increase in dosage

1 points  

Question 18

A nurse on an oncology unit is aware of the need to assess for adverse effects in patients who are being treated with rituximab. The risks of adverse effects are highest at what point during the course of treatment?

A.

48 to 72 hours after the first dose has been administered

B.

At each point that the dosage of rituximab is increased

C.

After 6 to 8 weeks of treatment at the maximum dose

D.

Shortly after the initiation of the first infusion of rituximab

1 points  

Question 19

Which of the following patients will be at the greatest risk for anemia and would be the most likely candidate for epoetin alfa therapy?

A.

A 62-year-old male with cancer

B.

A 40-year-old male with a high white blood cell count

C.

A 20-year-old female

D.

A 30-year-old pregnant woman

1 points  

Question 20

An oncology nurse is aware of the risks for injury that exist around the preparation, transportation, and administration of chemotherapeutic agents. In order to reduce these risks of injury, the nurse should take which of the following actions?

A.

Prime the IV tubing with an approved IV solution rather than with the drug itself.

B.

Use an IV system for administration that includes needles to reduce the risk of accidental spills.

C.

Encourage patients who have been receiving chemotherapy to use a bedside commode rather than a toilet.

D.

Dispose of intravenous lines used for chemotherapy administration in a covered trash can in the patient's room.

1 points  

Question 21

A nurse is discussing oprelvekin therapy with a male patient. Which of the following will the nurse tell the patient is the most common adverse effect of the drug?

A.

Fluid retention/weight gain

B.

Atrial arrhythmia

C.

Papilledema

D.

Medullary bone pain

1 points  

Question 22

A patient with non-Hodgkin's lymphoma (NHL) will be starting a course of doxorubicin shortly. When planning this patient's care, what nursing diagnosis should the nurse prioritize?

A.

Risk for Ineffective Airway Clearance related to decreased neurological function

B.

Risk for Infection related to suppressed bone marrow function

C.

Risk for Imbalanced Nutrition: More Than Body Requirements related to metabolic effects of doxorubicin

D.

Risk for Impaired Skin integrity related to cytotoxic effects of doxorubicin

1 points  

Question 23

A nurse is caring for a patient with cancer who has been prescribed dronabinol (Marinol) to help reduce nausea and vomiting from chemotherapy. The nurse will inform the patient that he or she is taking an oral form of

A.

cocaine.

B.

nicotine.

C.

marijuana.

D.

methamphetamine.

1 points  

Question 24

A patient has completed 4 weeks of treatment with epoetin alfa. Which of the following assessment findings would most strongly indicate that treatment has been effective?

A.

The patient white blood cell level is within reference ranges

B.

The patient maintains an oxygen saturation of 92% on room air

C.

The patient's hemoglobin level is 11 g/dL

D.

Capillary refill in the patient's nail beds is less than or equal to 3 seconds

1 points  

Question 25

A patient with chronic heart failure has begun treatment with epoetin alfa, which she will receive in her own home from a home health nurse. The nurse should teach the patient to supplement this treatment with a diet that is high in

A.

complex carbohydrates and vegetable-source proteins.

B.

protein and low in carbohydrates.

C.

calcium, such as dairy products, fish and vegetables.

D.

iron-rich foods such as beans and leafy green vegetables.

1 points  

Question 26

When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, the nurse should formulate which of the following patient outcomes? (Select all that apply.)

A.

The patient will not experience bone pain.

B.

The patient will be able to self-administer filgrastim at home.

C.

The patient will not develop an infection.

D.

The patient will not retain fluid.

E.

The patient will not develop febrile neutropenia.

1 points  

Question 27

A nurse is administering rituximab to a patient via the IV route. The nurse will set the IV pump at 50 mg/hour for the first half hour of the initial infusion. If there are not apparent reactions after 30 minutes of the infusion, the nurse will increase the dosage every 30 minutes by 50 mg/hour until the maximum infusion rate reaches which of the following?

A.

250 mg/hour

B.

400 mg/hour

C.

500 mg/hour

D.

300 mg/hour

1 points  

Question 28

A male patient is receiving heparin by continuous intravenous infusion. The nurse will instruct the patient and family members to report which of the following should it occur?

A.

A skin rash

B.

Sudden occurrence of sleepiness and drowsiness

C.

Presence of blood in urine or stools

D.

Dizziness

1 points  

Question 29

A nurse has administered filgrastim to a diverse group of patients in recent months. Which of the following patients should the nurse observe for extremely elevated white blood cell counts following administration of the drug?

A.

A 47-year-old male with aplastic anemia

B.

A 25-year-old female with a diagnosis of congenital neutropenia

C.

A 19-year-old male receiving radiotherapy

D.

A 39-year-old female with a nonmyeloid malignancy

1 points  

Question 30

Intravenous carmustine has been prescribed for a patient with cancer. The nurse should help relieve the discomfort of pain and burning during the infusion by

A.

decreasing the total volume of the primary IV infusion.

B.

decreasing the volume used for dilution.

C.

administering a dose of 2 units of bleomycin before carmustine.

D.

slowing the infusion.

1 points  

Question 31

A 39-year-old woman is receiving doxorubicin for the treatment of cancer. After each treatment, the patient has acute nausea and vomiting accompanied by a slightly increased heart rate. The nurse will advise her to

A.

take the drug only at bedtime.

B.

perform light exercise after administration of the drug.

C.

perform relaxation techniques after the treatments.

D.

make an appointment for cardiac function tests.

1 points  

Question 32

A patient with a recent diagnosis of chronic myelogenous leukemia (CML) is discussing treatment options with his care team. What aspect of the patient's condition would contraindicate the use of cyclophosphamide for the treatment of leukemia?

A.

The patient has a diagnosis of type 2 diabetes and takes oral antihyperglycemics.

B.

The patient has decreased renal function.

C.

The patient has had a history of nonadherence to medical treatment.

D.

The patient's bone marrow function is significantly depressed.

1 points  

Question 33

A female patient is prescribed oprelvekin therapy to treat thrombocytopenia. Which of the following should the nurse continuously monitor to determine the efficacy and duration of the oprelvekin therapy?

A.

Red and white blood cell count

B.

Weight gain

C.

Cardiac arrhythmias

D.

Platelet count

1 points  

Question 34

A nurse is to use a single-dose 1 mL vial to administer 0.5 mL of epoetin alfa to a 39-year-old woman who is being treated for chemotherapy-induced anemia. Which of the following will the nurse do with the unused portion of the drug?

A.

Store the medication in the drug cart for the next dose.

B.

Put the medication in the freezer compartment of the refrigerator.

C.

Refrigerate the medication for a future use.

D.

Discard the unused portion of the drug.

1 points  

Question 35

A patient's current course of cancer treatment involves the administration of a conjugated monoclonal antibody. What characteristic of the drug is specified by the fact that it is classified as a conjugated drug?

A.

The targeted therapy is combined with another substance that causes cell death.

B.

The targeted therapy is combination of a monoclonal antibody, a kinase inhibitor, and an inorganic cytotoxin.

C.

The drug is derived from nonhuman sources.

D.

The drug is able to adapt its pharmacokinetics to the etiology of the patient's cancer.